Medi-Caps EPS
The Earnings per Share (EPS) of Medi-Caps (523144.BO) as of Oct 10, 2026 is -2.44 INR. In the previous year, Earnings per Share (EPS) was -0.46 INR — a change of 431.96% (lower).
Get this data via API
Financial Data API
EPS
-2.44INR
YoY
431.96%
Last updated:
The Medi-Caps EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| -2.44INR | +431.96% | |
| -0.46INR | -74.52% | |
| -1.80INR | -227.62% | |
| 1.41INR | -82.58% | |
| 8.08INR | -9.42% | |
| 8.92INR | -290.18% | |
| -4.69INR | -208.63% | |
| 4.32INR | +369.44% | |
| 0.92INR | -16.11% | |
| 1.10INR | +58.36% | |
| 0.69INR | -141.94% | |
| -1.65INR | +58.84% | |
| -1.04INR | +83.08% | |
| -0.57INR | -146.41% | |
| 1.22INR | -43.54% | |
| 2.17INR | -25.14% | |
| 2.90INR | +1.12% | |
| 2.86INR | -74.52% | |
| 11.24INR | +70.92% | |
| 6.58INR | — |
Medi-Caps Stock analysis
Frequently Asked Questions about Medi-Caps stock
Earnings per Share (EPS) of Medi-Caps is -2.44 INR in 2026.
Earnings per Share (EPS) of Medi-Caps changed from -0.46 INR to -2.44 INR, representing a 431.96% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Medi-Caps since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Income Statement — Medi-Caps
All Key Metrics — Medi-Caps
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth